Sign in to continue:

Saturday, February 14th, 2026

Aspial Lifestyle Limited Announces Renounceable Non-Underwritten Rights Issue

Key Facts:

  • Rights Issue: Aspial Lifestyle Limited has proposed a renounceable non-underwritten rights issue of up to 311,843,500 new ordinary shares.
  • Issue Price: Each rights share is priced at S$0.12.
  • Allotment Ratio: Shareholders are entitled to one rights share for every five existing shares held, with fractional entitlements disregarded.
  • Record Date: The record date for determining shareholders’ eligibility will be announced later.
  • Discount: The issue price represents a discount of approximately 4.76% to the closing price of S$0.126 on August 21, 2024.
  • Purpose of Funds: Net proceeds of approximately S$37.22 million will be used for repaying bank borrowings (29.55%) and general working capital (70.45%).
  • Approval: The Singapore Exchange (SGX-ST) approved the listing and quotation of the new shares on August 29, 2024.

Investor Actions:

  • Eligible shareholders should monitor the upcoming announcement of the record date to determine their participation in the rights issue.
  • Consider the opportunity to participate in the rights issue at a discount to the market price.

Notable Points:

  • The rights issue aims to strengthen the company’s financial position and reduce its gearing ratio.
  • Controlling shareholder Aspial Corporation Limited intends to subscribe to its pro-rata entitlement.

Dates and Price Information:

  • Last Trading Day: August 21, 2024.
  • Issue Price: S$0.12 per share.
  • Listing and Quotation Notice Received: August 29, 2024.

Prudential plc Share Repurchase and Issued Shares Disclosure Report – November 2025

Prudential plc Share Repurchase Update: Key Details for Investors Prudential plc Announces Share Repurchase Activities and Changes in Issued Shares Key Points from the Latest Disclosure Return Issuer: Prudential plc Date of Disclosure: 19...

AJJ Medtech Holdings EGM 2026: Key Resolutions Passed, Change of Auditors & Performance Share Plan Approvals

AJJ Medtech Holdings Limited EGM: Key Resolutions Unanimously Passed — New Auditor Appointed and Major Share Grant to Controlling Shareholder Singapore, 7 January 2026 — AJJ Medtech Holdings Limited (“AJJ Medtech” or “the Company”)...

ClearBridge Health Secures SGX-ST Approval for 309.5 Million Share Placement

Clearbridge Health’s Bold Move: 309.5 Million New Shares Approved for Listing Clearbridge Health’s Bold Move: 309.5 Million New Shares Approved for Listing Clearbridge Health Limited, a key player in Singapore’s healthcare sector, has announced...

   Ad